Phase II trial of oxaliplatin (OXA) combined with paclitaxel (P) as first-line chemotherapy for patients (pts) with advanced ovarian cancer (AOC): Preliminary results

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5075-5075
Author(s):  
G. Deplanque ◽  
A. Goupil ◽  
M. Fabbro ◽  
E. Levy ◽  
O. Rixe ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Ovarian Cancer ◽  
First Line ◽  
Preliminary Results ◽  
Line Chemotherapy

Randomized phase II trial comparing IG-001 versus paclitaxel against first-line advanced ovarian cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 5590-5590
Author(s):  
Vuong N. Trieu ◽  
Monica Choi ◽  
Larn Hwang ◽  
Osmond D'Cruz
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Ovarian Cancer ◽  
First Line ◽  
Randomized Phase Ii

scholarly journals Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

2017 ◽  
Vol 147 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Nicole D. Fleming ◽  
Robert L. Coleman ◽  
Celestine Tung ◽  
Shannon N. Westin ◽  
Wei Hu ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
Dose Dense ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document